Journal profile · Medicine-Hematology
Research and Practice in Thrombosis and Haemostasis
ISSN 2475-0379 · Wiley-Blackwell · United States
Research and Practice in Thrombosis and Haemostasis: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.31; fully open access; APC about USD 2,990; median 86 days to acceptance (101 articles, last 24 months); 595 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Research and Practice in Thrombosis and Haemostasis is published by Wiley-Blackwell and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Venous Thromboembolism Diagnosis and Management, Hemophilia Treatment and Research and Platelet Disorders and Treatments, together about 38.6% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Research and Practice in Thrombosis and Haemostasis (RPTH) is the Open Access journal of the International Society on Thrombosis and Haemostasis (ISTH). Complementing its flagship journal, the Journal of Thrombosis and Haemostasis (JTH), RPTH provides a dedicated Open Access home for science and discourse.With eight issues published per year, RPTH is a living journal and serves as a launching pad for digital discussion. It also reflects the current era of inter-disciplinary scientific discovery and new methods of knowledge dissemination. RPTH provides rigorous, rapid peer review and immediate dissemination of research reports. The Journal is interested in quality, outcomes, dissemination and implementation science, seeking studies and trials on novel care delivery, including in areas of resource constraint around the world.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Hematology
Editor-in-chief Michael MakrisPublisher website
Editorial board by country: none in mainland China; most named United States 17, Netherlands 11, United Kingdom 10, Italy 6, Canada 6 (76 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Venous Thromboembolism Diagnosis and ManagementMedicine15.2%
- Hemophilia Treatment and ResearchMedicine11.8%
- Platelet Disorders and TreatmentsMedicine11.6%
- Blood Coagulation and Thrombosis MechanismsMedicine11%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine5.7%
- Blood properties and coagulationMedicine5.4%
- Atrial Fibrillation Management and OutcomesMedicine5.1%
- Coagulation, Bradykinin, Polyphosphates, and AngioedemaMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.31LetPub ·
- Impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher)
- 4.7Publisher website ·
- SJR 2026-06
- 1.07LetPub ·
- SNIP 2026-06
- 1.23LetPub ·
- h-index
- 57OpenAlex ·
- i10-index
- 657OpenAlex ·
- 2-year mean citedness
- 1.82OpenAlex ·
- Self-citation rate
- 8.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 261LetPub ·
Articles by year OpenAlex count · 4,375 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 430 | 430 | 92 |
| 2025 | 595 | 595 | 739 |
| 2024 | 319 | 319 | 1,620 |
| 2023 | 2,132 | 2,132 | 3,615 |
| 2022 | 224 | 224 | 2,770 |
| 2021 | 183 | 183 | 2,552 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
86 daysMedian, submission to acceptance · P25–P75 42 days – 133 days
- Acceptance to online
- median 18 days (101 articles)
- Submission to online
- median 102 days
- Sample
- 101 articles with submission and acceptance dates (689 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 7 weeksLetPub ·
- Submission to acceptance
- 104 daysPublisher website ·
- Submission to publication (journal-reported)
- about 21 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,990 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,250 / EUR 2,100 / GBP 1,800 / JPY 279,070 | — | — | |
| LetPub | USD 2,250 | Yes | — | |
| Publisher website | USD 2,990 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted14
- brief reportWord count suggestions for each article type (EXCLUDING THE ABSTRACT) are a guide only, and we suggest them since we value concise communication to improve unde…Length not stated
- brief reportsSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- case reportsSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- editorialWord count suggestions for each article type (EXCLUDING THE ABSTRACT) are a guide only, and we suggest them since we value concise communication to improve unde…Length not stated
- forumsSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- illustrated review articlesSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- letters to the editorSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- original articleWord count suggestions for each article type (EXCLUDING THE ABSTRACT) are a guide only, and we suggest them since we value concise communication to improve unde…Length not stated
- original articlesSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- recommendations and guidelinesSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- reviewWord count suggestions for each article type (EXCLUDING THE ABSTRACT) are a guide only, and we suggest them since we value concise communication to improve unde…Length not stated
- review articleWord count suggestions for each article type (EXCLUDING THE ABSTRACT) are a guide only, and we suggest them since we value concise communication to improve unde…Length not stated
- review articlesSubmission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
- state of the art review articles (invited only)Submission types are: Review Articles; Illustrated Review Articles; State of the Art Review Articles (invited only); Original Articles; Brief Reports; Forums; L…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Plagiarism, Preprints, Self-archiving
- AI use Declaration of generative AI in scientific writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human o…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include: EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board…
Source ↗Publisher website ·- License & copyright Copyright.
Upon acceptance, authors asked to complete an 'Exclusive License Agreement'; permitted third party reuse of open access articles determined by author's choice of user license. Model summary
Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information. Note that Letters to the Editor, Editorials & Commentaries are not charged any APC?s.
Source ↗Publisher website ·- Peer review
Follows ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals Model summary
RPTH follows the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals
Source ↗Publisher website ·- Plagiarism
On resubmission, all manuscripts subject to plagiarism check using iThenticate software. Model summary
On resubmission, all manuscripts will be subject to a plagiarism check using iThenticate software to detect instances of
Source ↗Publisher website ·- Preprints Preprint Servers
Considers articles previously available as preprints on non-commercial servers; authors may post submitted version to non-commercial servers at any time; authors requested to update pre-publication versions with link to final published article. Model summary
RPTH will consider articles for peer review that were previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, etc. Authors may also post the submitted version of their manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
Source ↗Publisher website ·- Self-archiving
Papers submitted by editors or board members (including as co-author) handled by other Senior Editors; submission system does not allow Editors to manage their own papers. Model summary
A paper submitted by an editor or board member (including submission as a co-author) will be handled by one of the other Senior Editors who will manage the peer review process. The Journal's submission system does not allow Editors to manage their own papers in the system.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- United States
- Language
- English
- ISSN
- 2475-0379
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Research and Practice in Thrombosis and Haemostasis
What CAS zone is Research and Practice in Thrombosis and Haemostasis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Research and Practice in Thrombosis and Haemostasis is in Zone 3 of Medicine, and in Zone 3 of the minor category Hematology / Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Research and Practice in Thrombosis and Haemostasis?
The latest impact factor listed by LetPub is 3.31; CiteScore 4.7, h-index 57.
How long does peer review take at Research and Practice in Thrombosis and Haemostasis?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 86 days (interquartile range 42–133 days); authors report an average review time of about 7 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Research and Practice in Thrombosis and Haemostasis based?
Of the 76 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (17), Netherlands (11) and United Kingdom (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Research and Practice in Thrombosis and Haemostasis?
According to LetPub and DOAJ records, Research and Practice in Thrombosis and Haemostasis is indexed in SCIE, Scopus and DOAJ.
Is Research and Practice in Thrombosis and Haemostasis open access, and what is the APC?
Research and Practice in Thrombosis and Haemostasis is a fully open-access journal. APC about USD 2,990.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .